Target (CBDY) Work In Process (2023 - 2026)

Target (CBDY) reported Work In Process of $449581.0 for Q1 2026, up 29.45% year-over-year from $347303.0 in Q1 2025, and down 36.57% quarter-over-quarter from $708777.0 in Q4 2025.

Target (CBDY) Work In Process (2023 - 2026) Analysis & Trends

Target (CBDY) has 4 years of Work In Process data on file, last reported at $449581.0 in Q1 2026.

  • Work In Process for Q1 2026 came in at $449581.0, up 29.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $449581.0 (up 29.45% YoY), and the FY2025 annual result was $708777.0, up 42.09% from the prior year.
  • Work In Process eased to $449581.0 in Q1 2026 per CBDY's latest filing, from $708777.0 in the prior quarter.
  • Over five years, Work In Process peaked at $762790.0 in Q3 2025 and troughed at $256230.0 in Q2 2024.
  • A 4-year average of $483567.4 and a median of $459910.0 in 2024 frame the typical range for Work In Process.
  • The sharpest annual moves came in 2024 and 2025: Work In Process rose 15.58% in 2024, then surged 149.88% in 2025.
  • A 4-year view of Work In Process shows it stood at $431574.0 in 2023, then rose by 15.58% to $498820.0 in 2024, then jumped by 42.09% to $708777.0 in 2025, then slumped by 36.57% to $449581.0 in 2026.
  • Business Quant data shows CBDY's Work In Process at $449581.0 in Q1 2026, $708777.0 in Q4 2025, and $762790.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Target - - 191,787.00

Historic Data

Download Data
DateValue
Mar 31, 2026 449,581.00
Dec 31, 2025 708,777.00
Sep 30, 2025 762,790.00
Jun 30, 2025 640,279.00
Mar 31, 2025 347,303.00
Dec 31, 2024 498,820.00
Sep 30, 2024 470,239.00
Jun 30, 2024 256,230.00
Mar 31, 2024 270,081.00
Dec 31, 2023 431,574.00